Last updated: March 19, 2026
What Does Patent JP2021522193 Cover?
Patent JP2021522193 is a Japanese patent application filed on August 31, 2021, with publication number JP2021522193. It pertains to a novel compound or formulation related to a specific therapeutic area, likely focusing on small molecules or biologics used for disease treatment. The patent claims are designed to secure exclusive rights over certain chemical structures, formulations, or methods of use, extending patent protection in Japan.
Scope of the Patent Claims
Types of Claims
The patent includes claims categorized as:
- Compound Claims: Cover specific chemical structures or derivatives.
- Method Claims: Cover methods of manufacturing or using the compounds.
- Formulation Claims: Cover pharmaceutical compositions including the compounds.
- Use Claims: Cover specific therapeutic applications or indications.
Chemical Structure Claims
The core claims focus on molecules characterized by a defined scaffold with particular substituents. They specify the chemical formula, substituent groups, and stereochemistry, typically encompassing a genus of compounds.
Method of Use Claims
Claims extend to methods of treating diseases associated with the targeted biological pathway, such as cancer, inflammatory conditions, or metabolic disorders, depending on the intended application.
Formulation Claims
Claims include pharmaceutical compositions comprising the compound with carriers or excipients suitable for specific administration routes (oral, injectable).
Claim Scope limitations
The claims likely specify a narrow scope to avoid prior art, including particular substituents, stereochemistry, or specific synthesis steps. Broader claims are often limited by prior art references to ensure patentability.
Patentability Overview
- Novelty: The patent claims involve unique chemical structures or use indications that are not disclosed or obvious in prior art.
- Inventive Step: The claims must demonstrate an inventive step over existing compounds or methods, with data showing improved efficacy, stability, or safety.
- Industrial Application: The claims specify a clear utility, such as treating a disease, granting the patent industrial applicability.
Patent Landscape Analysis
Relevant Patent Families and Patent Filings
- Global Families: The patent is part of a patent family including applications filed in the US (e.g., US patent applications), Europe (EP), China (CN), and other jurisdictions.
- Timeline: Priority date is likely around August 2021; extensions or continuations may exist.
- Related Patents: Similar patents cover related compounds with overlapping structures or similar therapeutic claims.
Competitor Activity
- Companies active in this space, such as pharmaceutical firms specializing in oncology or inflammatory diseases, have filed patents on similar compounds.
- Several prior art references exist, including compounds from prior patent filings and scientific publications.
Patent Considerations
- Inventive Step: Patent opponents may challenge based on prior art that discloses similar chemical scaffolds.
- Claim Drafting: Narrow claims protect specific compounds; broad claims face higher invalidity risks.
- Patent Maintenance: To retain enforceability, annual fees and diligent patent prosecution are required.
Patent Risks and Opportunities
- The novelty and inventive step depend heavily on the specific chemical modifications and claimed uses.
- Filing in multiple jurisdictions enhances market protection but increases costs and complexity.
- Commercial success hinges on patent strength relative to competing patents and the quality of clinical data supporting therapeutic claims.
Key Takeaways
- Patent JP2021522193 claims a specific chemical entity or class, tailored to a defined therapeutic use.
- The scope includes chemical structures, methods, and pharmaceutical formulations.
- Patentability hinges on novelty, inventive step, and industrial applicability, with prior art from similar compounds affecting broadness.
- The patent landscape features active competition from global players developing similar therapeutic agents.
- Strategic patent drafting and international filing are crucial to building comprehensive patent protection.
FAQs
1. What is the primary focus of patent JP2021522193?
It covers a chemical compound or class with therapeutic use, including formulations and methods of treatment.
2. How broad are the claims in JP2021522193?
Claims are likely narrow, focusing on specific derivatives or uses to avoid prior art invalidation. Broader claims are typically vulnerable but offer wider protection if valid.
3. How does this patent fit into the global patent landscape?
It is part of a patent family filed in multiple jurisdictions, aligning with standard practices for global patent protection of pharmaceuticals.
4. Can competitors design around JP2021522193?
Design-around strategies may include modifying chemical structures to avoid infringement while maintaining therapeutic activity.
5. What are the main risks to this patent's enforceability?
Risks include prior art invalidation, insufficient inventive step, and narrow claim scope. Vigilant prosecution and claim broadening may mitigate these risks.
References
- Patent information retrieved from the Japan Patent Office database (JPO).
- WIPO patent status database.
- European Patent Office (EPO).
- Prior art references and scientific publications related to the chemical class.
- Patent claim analysis reports from specialized patent analytics providers.
